Susquehanna International Group
FENC icon

Susquehanna International Group’s Fennec Pharmaceuticals FENC Stock Holding History

Susquehanna International Group’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$138K Buy
+22,400
New +$173K ﹤0.01% 12096
2024
Q2 		– Sell
-26,800
Closed -$298K – 12354
2024
Q1 		$298K Sell
26,800
-17,400
-39% -$175K ﹤0.01% 9701
2023
Q4 		$496K Buy
44,200
+27,900
+171% +$231K ﹤0.01% 8683
2023
Q3 		$122K Sell
16,300
-35,600
-69% -$290K ﹤0.01% 10753
2023
Q2 		$458K Sell
51,900
-10,900
-17% -$90.6K ﹤0.01% 8525
2023
Q1 		$522K Sell
62,800
-89,900
-59% -$834K ﹤0.01% 8451
2022
Q4 		$1.47M Buy
152,700
+117,400
+333% +$1.04M ﹤0.01% 5340
2022
Q3 		$286K Sell
35,300
-21,300
-38% -$146K ﹤0.01% 9912
2022
Q2 		$320K Buy
56,600
+16,500
+41% +$95.7K ﹤0.01% 9409
2022
Q1 		$225K Buy
40,100
+2,400
+6% +$12.1K ﹤0.01% 10954
2021
Q4 		$166K Buy
37,700
+21,600
+134% +$161K ﹤0.01% 11672
2021
Q3 		$152K Sell
16,100
-20,600
-56% -$155K ﹤0.01% 11770
2021
Q2 		$268K Buy
+36,700
New +$245K ﹤0.01% 11016
2020
Q4 		– Sell
-14,300
Closed -$87K – 11200
2020
Q3 		$87K Buy
+14,300
New +$101K ﹤0.01% 9988

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

Susquehanna International Group's FENC Position: Q4 2025 in Review

Susquehanna International Group sold out of Fennec Pharmaceuticals (FENC) in Q4 2025, closing a stake of 17,023 shares — an estimated $159K sold.

Susquehanna International Group first reported a position in FENC in Q1 2018 and held it in 21 quarters. The position peaked at $1.34M in Q1 2023. 96 funds tracked by Wall St. Rank hold FENC as of Q4 2025.

  • Susquehanna International Group reported no remaining Fennec Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 17,023 Fennec Pharmaceuticals shares in Q4 2025, an estimated $159K.
  • Susquehanna International Group first reported a position in Fennec Pharmaceuticals in Q1 2018 and held it in 21 quarters.
  • Susquehanna International Group's Fennec Pharmaceuticals position peaked at $1.34M in Q1 2023.
  • 96 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.